| 名稱 | FGFR2-AHCYL1/BaF3 |
| 型號 | CBP73267 |
| 報價 |  |
| 特點 | FGFR2-AHCYL1/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73267FGFR2-AHCYL1/BaF3
- 詳細(xì)內(nèi)容
CBP73267 | |
| I. Introduction | |
Cell Line Name： | FGFR2-AHCYL1/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
FGFR2-AHCYL1 results from the fusion of FGFR2 and AHCYL1, resulting in the ability to activate MAPK signaling and induce transformation of cells in culture and in animal models (PMID: 24122810). FGFR2-AHCYL1 has been identified in intrahepatic cholangiocarcinoma (PMID: 24122810). | |
| III. Representative Data | |
1. WB of FGFR2-AHCYL1/BaF3
| |
2. Sanger of FGFR2-AHCYL1/BaF3
| |
3. Anti-proliferation assay | |
| |
Figure 3. CTG Proliferation Assay of BaF3 FGFR2-AHCYL1 Cells(C1) | |
